<?xml version='1.0' encoding='UTF-8'?>
<uniprot xmlns="http://uniprot.org/uniprot"
				 xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
				 xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
	<entry dataset="Swiss-Prot" created="1988-11-01" modified="2012-05-16"
				 version="145">
		<accession>P08913</accession>
		<accession>B0LPF6</accession>
		<accession>Q2I8G2</accession>
		<accession>Q2XN99</accession>
		<accession>Q86TH8</accession>
		<accession>Q9BZK1</accession>
		<name>ADA2A_HUMAN</name>
		<protein>
			<recommendedName>
				<fullName>Alpha-2A adrenergic receptor</fullName>
			</recommendedName>
			<alternativeName>
				<fullName>Alpha-2 adrenergic receptor subtype C10</fullName>
			</alternativeName>
			<alternativeName>
				<fullName>Alpha-2A adrenoreceptor</fullName>
				<shortName>Alpha-2A adrenoceptor</shortName>
				<shortName>Alpha-2AAR</shortName>
			</alternativeName>
		</protein>
		<gene>
			<name type="primary">ADRA2A</name>
			<name type="synonym">ADRA2R</name>
			<name type="synonym">ADRAR</name>
		</gene>
		<organism>
			<name type="scientific">Homo sapiens</name>
			<name type="common">Human</name>
			<dbReference type="NCBI Taxonomy" id="9606"/>
			<lineage>
				<taxon>Eukaryota</taxon>
				<taxon>Metazoa</taxon>
				<taxon>Chordata</taxon>
				<taxon>Craniata</taxon>
				<taxon>Vertebrata</taxon>
				<taxon>Euteleostomi</taxon>
				<taxon>Mammalia</taxon>
				<taxon>Eutheria</taxon>
				<taxon>Euarchontoglires</taxon>
				<taxon>Primates</taxon>
				<taxon>Haplorrhini</taxon>
				<taxon>Catarrhini</taxon>
				<taxon>Hominidae</taxon>
				<taxon>Homo</taxon>
			</lineage>
		</organism>
		<reference key="1">
			<citation type="journal article" date="1987" name="Science" volume="238"
								first="650" last="656">
				<title>Cloning, sequencing, and expression of the gene coding for the
					human platelet alpha 2-adrenergic receptor.
				</title>
				<authorList>
					<person name="Kobilka B.K."/>
					<person name="Matsui H."/>
					<person name="Kobilka T.S."/>
					<person name="Yang-Feng T.L."/>
					<person name="Francke U."/>
					<person name="Caron M.G."/>
					<person name="Lefkowitz R.J."/>
					<person name="Regan J.W."/>
				</authorList>
				<dbReference type="MEDLINE" id="88042789"/>
				<dbReference type="PubMed" id="2823383"/>
				<dbReference type="DOI" id="10.1126/science.2823383"/>
			</citation>
			<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
			<scope>PARTIAL PROTEIN SEQUENCE</scope>
			<source>
				<tissue>Platelet</tissue>
			</source>
		</reference>
		<reference key="2">
			<citation type="journal article" date="1989" name="J. Biol. Chem."
								volume="264" first="11754" last="11761">
				<title>Cloning, sequence analysis, and permanent expression of a human
					alpha 2-adrenergic receptor in Chinese hamster ovary cells. Evidence
					for independent pathways of receptor coupling to adenylate cyclase
					attenuation and activation.
				</title>
				<authorList>
					<person name="Fraser C.M."/>
					<person name="Arakawa S."/>
					<person name="McCombie W.R."/>
					<person name="Venter J.C."/>
				</authorList>
				<dbReference type="MEDLINE" id="89308571"/>
				<dbReference type="PubMed" id="2568356"/>
			</citation>
			<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
		</reference>
		<reference key="3">
			<citation type="journal article" date="1990" name="J. Biol. Chem."
								volume="265" first="17307" last="17317">
				<title>Cloning, sequencing, and expression of the gene encoding the
					porcine alpha 2-adrenergic receptor. Allosteric modulation by Na+, H+,
					and amiloride analogs.
				</title>
				<authorList>
					<person name="Guyer C.A."/>
					<person name="Horstman D.A."/>
					<person name="Wilson A.L."/>
					<person name="Clark J.D."/>
					<person name="Kragoe E.J. Jr."/>
					<person name="Limbird L.E."/>
				</authorList>
				<dbReference type="MEDLINE" id="91009167"/>
				<dbReference type="PubMed" id="2170371"/>
			</citation>
			<scope>SEQUENCE REVISION TO 333-365</scope>
		</reference>
		<reference key="4">
			<citation type="journal article" date="2000" name="J. Biol. Chem."
								volume="275" first="38518" last="38523">
				<title>An Asn to Lys polymorphism in the third intracellular loop of the
					human alpha 2A-adrenergic receptor imparts enhanced agonist-promoted
					Gi coupling.
				</title>
				<authorList>
					<person name="Small K.M."/>
					<person name="Forbes S.L."/>
					<person name="Brown K.M."/>
					<person name="Liggett S.B."/>
				</authorList>
				<dbReference type="PubMed" id="10948191"/>
				<dbReference type="DOI" id="10.1074/jbc.M004550200"/>
			</citation>
			<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
			<scope>VARIANT LYS-251</scope>
		</reference>
		<reference key="5">
			<citation type="journal article" date="2006"
								name="Proc. Natl. Acad. Sci. U.S.A." volume="103" first="5472"
								last="5477">
				<title>Complex haplotypes derived from noncoding polymorphisms of the
					intronless alpha-2A-adrenergic gene diversify receptor expression.
				</title>
				<authorList>
					<person name="Small K.M."/>
					<person name="Brown K.M."/>
					<person name="Seman C.A."/>
					<person name="Theiss C.T."/>
					<person name="Liggett S.B."/>
				</authorList>
				<dbReference type="PubMed" id="16567612"/>
				<dbReference type="DOI" id="10.1073/pnas.0601345103"/>
			</citation>
			<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
			<scope>VARIANT LYS-251</scope>
		</reference>
		<reference key="6">
			<citation type="submission" date="2000-07"
								db="EMBL/GenBank/DDBJ databases">
				<title>Cloning and expression of human alpha-2A adrenergic receptor in
					SY5Y cells.
				</title>
				<authorList>
					<person name="Mao Z.-M."/>
					<person name="Tang K."/>
					<person name="Li B.-M."/>
					<person name="Jing N.-H."/>
				</authorList>
			</citation>
			<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
		</reference>
		<reference key="7">
			<citation type="submission" date="2000-08"
								db="EMBL/GenBank/DDBJ databases">
				<title>A search for genetic variability in the human alpha-2 adrenergic
					receptor on chromosome 10.
				</title>
				<authorList>
					<person name="Castellano M."/>
					<person name="Giacche' M."/>
					<person name="Rossi F."/>
					<person name="Rivadossi F."/>
					<person name="Perani C."/>
					<person name="Beschi M."/>
					<person name="Agabiti Rosei E."/>
				</authorList>
			</citation>
			<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
		</reference>
		<reference key="8">
			<citation type="submission" date="2001-04"
								db="EMBL/GenBank/DDBJ databases">
				<title>Human alpha-2A adrenergic receptor gene and the genotype of -1296
					nucleotide and motionsickness.
				</title>
				<authorList>
					<person name="Liu L."/>
					<person name="Yuan L."/>
				</authorList>
			</citation>
			<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
		</reference>
		<reference key="9">
			<citation type="submission" date="2005-11"
								db="EMBL/GenBank/DDBJ databases">
				<authorList>
					<consortium name="SeattleSNPs variation discovery resource"/>
				</authorList>
			</citation>
			<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
			<scope>VARIANT LYS-251</scope>
		</reference>
		<reference key="10">
			<citation type="submission" date="2007-12"
								db="EMBL/GenBank/DDBJ databases">
				<authorList>
					<consortium
						name="NHLBI resequencing and genotyping service (RS&amp;G)"/>
				</authorList>
			</citation>
			<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
		</reference>
		<reference key="11">
			<citation type="journal article" date="2004" name="Nature" volume="429"
								first="375" last="381">
				<title>The DNA sequence and comparative analysis of human chromosome
					10.
				</title>
				<authorList>
					<person name="Deloukas P."/>
					<person name="Earthrowl M.E."/>
					<person name="Grafham D.V."/>
					<person name="Rubenfield M."/>
					<person name="French L."/>
					<person name="Steward C.A."/>
					<person name="Sims S.K."/>
					<person name="Jones M.C."/>
					<person name="Searle S."/>
					<person name="Scott C."/>
					<person name="Howe K."/>
					<person name="Hunt S.E."/>
					<person name="Andrews T.D."/>
					<person name="Gilbert J.G.R."/>
					<person name="Swarbreck D."/>
					<person name="Ashurst J.L."/>
					<person name="Taylor A."/>
					<person name="Battles J."/>
					<person name="Bird C.P."/>
					<person name="Ainscough R."/>
					<person name="Almeida J.P."/>
					<person name="Ashwell R.I.S."/>
					<person name="Ambrose K.D."/>
					<person name="Babbage A.K."/>
					<person name="Bagguley C.L."/>
					<person name="Bailey J."/>
					<person name="Banerjee R."/>
					<person name="Bates K."/>
					<person name="Beasley H."/>
					<person name="Bray-Allen S."/>
					<person name="Brown A.J."/>
					<person name="Brown J.Y."/>
					<person name="Burford D.C."/>
					<person name="Burrill W."/>
					<person name="Burton J."/>
					<person name="Cahill P."/>
					<person name="Camire D."/>
					<person name="Carter N.P."/>
					<person name="Chapman J.C."/>
					<person name="Clark S.Y."/>
					<person name="Clarke G."/>
					<person name="Clee C.M."/>
					<person name="Clegg S."/>
					<person name="Corby N."/>
					<person name="Coulson A."/>
					<person name="Dhami P."/>
					<person name="Dutta I."/>
					<person name="Dunn M."/>
					<person name="Faulkner L."/>
					<person name="Frankish A."/>
					<person name="Frankland J.A."/>
					<person name="Garner P."/>
					<person name="Garnett J."/>
					<person name="Gribble S."/>
					<person name="Griffiths C."/>
					<person name="Grocock R."/>
					<person name="Gustafson E."/>
					<person name="Hammond S."/>
					<person name="Harley J.L."/>
					<person name="Hart E."/>
					<person name="Heath P.D."/>
					<person name="Ho T.P."/>
					<person name="Hopkins B."/>
					<person name="Horne J."/>
					<person name="Howden P.J."/>
					<person name="Huckle E."/>
					<person name="Hynds C."/>
					<person name="Johnson C."/>
					<person name="Johnson D."/>
					<person name="Kana A."/>
					<person name="Kay M."/>
					<person name="Kimberley A.M."/>
					<person name="Kershaw J.K."/>
					<person name="Kokkinaki M."/>
					<person name="Laird G.K."/>
					<person name="Lawlor S."/>
					<person name="Lee H.M."/>
					<person name="Leongamornlert D.A."/>
					<person name="Laird G."/>
					<person name="Lloyd C."/>
					<person name="Lloyd D.M."/>
					<person name="Loveland J."/>
					<person name="Lovell J."/>
					<person name="McLaren S."/>
					<person name="McLay K.E."/>
					<person name="McMurray A."/>
					<person name="Mashreghi-Mohammadi M."/>
					<person name="Matthews L."/>
					<person name="Milne S."/>
					<person name="Nickerson T."/>
					<person name="Nguyen M."/>
					<person name="Overton-Larty E."/>
					<person name="Palmer S.A."/>
					<person name="Pearce A.V."/>
					<person name="Peck A.I."/>
					<person name="Pelan S."/>
					<person name="Phillimore B."/>
					<person name="Porter K."/>
					<person name="Rice C.M."/>
					<person name="Rogosin A."/>
					<person name="Ross M.T."/>
					<person name="Sarafidou T."/>
					<person name="Sehra H.K."/>
					<person name="Shownkeen R."/>
					<person name="Skuce C.D."/>
					<person name="Smith M."/>
					<person name="Standring L."/>
					<person name="Sycamore N."/>
					<person name="Tester J."/>
					<person name="Thorpe A."/>
					<person name="Torcasso W."/>
					<person name="Tracey A."/>
					<person name="Tromans A."/>
					<person name="Tsolas J."/>
					<person name="Wall M."/>
					<person name="Walsh J."/>
					<person name="Wang H."/>
					<person name="Weinstock K."/>
					<person name="West A.P."/>
					<person name="Willey D.L."/>
					<person name="Whitehead S.L."/>
					<person name="Wilming L."/>
					<person name="Wray P.W."/>
					<person name="Young L."/>
					<person name="Chen Y."/>
					<person name="Lovering R.C."/>
					<person name="Moschonas N.K."/>
					<person name="Siebert R."/>
					<person name="Fechtel K."/>
					<person name="Bentley D."/>
					<person name="Durbin R.M."/>
					<person name="Hubbard T."/>
					<person name="Doucette-Stamm L."/>
					<person name="Beck S."/>
					<person name="Smith D.R."/>
					<person name="Rogers J."/>
				</authorList>
				<dbReference type="PubMed" id="15164054"/>
				<dbReference type="DOI" id="10.1038/nature02462"/>
			</citation>
			<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
		</reference>
		<reference key="12">
			<citation type="journal article" date="2004" name="Genome Res."
								volume="14" first="2121" last="2127">
				<title>The status, quality, and expansion of the NIH full-length cDNA
					project: the Mammalian Gene Collection (MGC).
				</title>
				<authorList>
					<consortium name="The MGC Project Team"/>
				</authorList>
				<dbReference type="PubMed" id="15489334"/>
				<dbReference type="DOI" id="10.1101/gr.2596504"/>
			</citation>
			<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
			<source>
				<tissue>PNS</tissue>
				<tissue>Testis</tissue>
			</source>
		</reference>
		<reference key="13">
			<citation type="journal article" date="1991" name="FEBS Lett."
								volume="280" first="241" last="244">
				<title>Identification of an additional gene belonging to the alpha 2
					adrenergic receptor family in the human genome by PCR.
				</title>
				<authorList>
					<person name="Chhajlani V."/>
					<person name="Rangel N."/>
					<person name="Uhlen S."/>
					<person name="Wikberg J.E.S."/>
				</authorList>
				<dbReference type="MEDLINE" id="91192139"/>
				<dbReference type="PubMed" id="1849485"/>
				<dbReference type="DOI" id="10.1016/0014-5793(91)80301-I"/>
			</citation>
			<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 77-209</scope>
		</reference>
		<reference key="14">
			<citation type="journal article" date="1991" name="J. Biol. Chem."
								volume="266" first="15488" last="15492">
				<title>A point mutation in the seventh hydrophobic domain of the alpha 2
					adrenergic receptor increases its affinity for a family of beta
					receptor antagonists.
				</title>
				<authorList>
					<person name="Suryanarayana S."/>
					<person name="Daunt D.A."/>
					<person name="von Zastrow M."/>
					<person name="Kobilka B.K."/>
				</authorList>
				<dbReference type="MEDLINE" id="91332079"/>
				<dbReference type="PubMed" id="1678390"/>
			</citation>
			<scope>MUTAGENESIS OF PHE-412</scope>
		</reference>
		<reference key="15">
			<citation type="journal article" date="1991" name="Mol. Pharmacol."
								volume="40" first="168" last="179">
				<title>Site-directed mutagenesis of alpha 2a-adrenergic receptors:
					Identification of amino acids involved in ligand binding and receptor
					activation by agonists.
				</title>
				<authorList>
					<person name="Wang C.-D."/>
					<person name="Buck M.A."/>
					<person name="Fraser C.M."/>
				</authorList>
				<dbReference type="MEDLINE" id="91342598"/>
				<dbReference type="PubMed" id="1678850"/>
			</citation>
			<scope>MUTAGENESIS OF ASPARTIC ACID AND SERINE RESIDUES</scope>
		</reference>
		<reference key="16">
			<citation type="journal article" date="2006" name="Cell" volume="127"
								first="635" last="648">
				<title>Global, in vivo, and site-specific phosphorylation dynamics in
					signaling networks.
				</title>
				<authorList>
					<person name="Olsen J.V."/>
					<person name="Blagoev B."/>
					<person name="Gnad F."/>
					<person name="Macek B."/>
					<person name="Kumar C."/>
					<person name="Mortensen P."/>
					<person name="Mann M."/>
				</authorList>
				<dbReference type="PubMed" id="17081983"/>
				<dbReference type="DOI" id="10.1016/j.cell.2006.09.026"/>
			</citation>
			<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-297; SER-298 AND
				SER-299
			</scope>
			<scope>MASS SPECTROMETRY</scope>
			<source>
				<tissue>Cervix carcinoma</tissue>
			</source>
		</reference>
		<reference key="17">
			<citation type="journal article" date="2002" name="Biochemistry"
								volume="41" first="3596" last="3604">
				<title>NMR structure of the second intracellular loop of the alpha 2A
					adrenergic receptor: evidence for a novel cytoplasmic helix.
				</title>
				<authorList>
					<person name="Chung D.A."/>
					<person name="Zuiderweg E.R.P."/>
					<person name="Fowler C.B."/>
					<person name="Soyer O.S."/>
					<person name="Mosberg H.I."/>
					<person name="Neubig R.R."/>
				</authorList>
				<dbReference type="MEDLINE" id="21885815"/>
				<dbReference type="PubMed" id="11888275"/>
				<dbReference type="DOI" id="10.1021/bi015811+"/>
			</citation>
			<scope>STRUCTURE BY NMR OF 118-149</scope>
			<scope>PROBABLE MEMBRANE TOPOLOGY</scope>
		</reference>
		<comment type="function">
			<text>Alpha-2 adrenergic receptors mediate the catecholamine-induced
				inhibition of adenylate cyclase through the action of G proteins. The
				rank order of potency for agonists of this receptor is oxymetazoline >
				clonidine > epinephrine > norepinephrine > phenylephrine > dopamine >
				p-synephrine > p-tyramine > serotonin = p-octopamine. For antagonists,
				the rank order is yohimbine > phentolamine = mianserine > chlorpromazine
				= spiperone = prazosin > propanolol > alprenolol = pindolol.
			</text>
		</comment>
		<comment type="subcellular location">
			<subcellularLocation>
				<location>Cell membrane</location>
				<topology>Multi-pass membrane protein</topology>
			</subcellularLocation>
		</comment>
		<comment type="similarity">
			<text>Belongs to the G-protein coupled receptor 1 family. Adrenergic
				receptor subfamily. ADRA2A sub-subfamily.
			</text>
		</comment>
		<comment type="online information" name="SeattleSNPs">
			<link uri="http://pga.gs.washington.edu/data/adra2a/"/>
		</comment>
		<dbReference type="EMBL" id="M18415">
			<property type="protein sequence ID" value="AAA51664.1"/>
			<property type="molecule type" value="Genomic_DNA"/>
		</dbReference>
		<dbReference type="EMBL" id="M23533">
			<property type="protein sequence ID" value="AAA51665.1"/>
			<property type="molecule type" value="Genomic_DNA"/>
		</dbReference>
		<dbReference type="EMBL" id="AF281308">
			<property type="protein sequence ID" value="AAF91441.1"/>
			<property type="molecule type" value="Genomic_DNA"/>
		</dbReference>
		<dbReference type="EMBL" id="AF316894">
			<property type="protein sequence ID" value="AAK01634.1"/>
			<property type="molecule type" value="Genomic_DNA"/>
		</dbReference>
		<dbReference type="EMBL" id="DQ149926">
			<property type="protein sequence ID" value="AAZ73101.1"/>
			<property type="molecule type" value="Genomic_DNA"/>
		</dbReference>
		<dbReference type="EMBL" id="AF284095">
			<property type="protein sequence ID" value="AAK26743.1"/>
			<property type="molecule type" value="mRNA"/>
		</dbReference>
		<dbReference type="EMBL" id="AF262016">
			<property type="protein sequence ID" value="AAG00447.2"/>
			<property type="molecule type" value="Genomic_DNA"/>
		</dbReference>
		<dbReference type="EMBL" id="AY032736">
			<property type="protein sequence ID" value="AAK51162.1"/>
			<property type="molecule type" value="Genomic_DNA"/>
		</dbReference>
		<dbReference type="EMBL" id="DQ285607">
			<property type="protein sequence ID" value="ABB72683.1"/>
			<property type="molecule type" value="Genomic_DNA"/>
		</dbReference>
		<dbReference type="EMBL" id="EU332846">
			<property type="protein sequence ID" value="ABY87535.1"/>
			<property type="molecule type" value="Genomic_DNA"/>
		</dbReference>
		<dbReference type="EMBL" id="AL158163">
			<property type="protein sequence ID" value="CAH72817.1"/>
			<property type="molecule type" value="Genomic_DNA"/>
		</dbReference>
		<dbReference type="EMBL" id="BC035047">
			<property type="protein sequence ID" value="AAH35047.1"/>
			<property type="molecule type" value="mRNA"/>
		</dbReference>
		<dbReference type="EMBL" id="BC050414">
			<property type="protein sequence ID" value="AAH50414.4"/>
			<property type="molecule type" value="mRNA"/>
		</dbReference>
		<dbReference type="IPI" id="IPI00797870"/>
		<dbReference type="PIR" id="A34169">
			<property type="entry name" value="A34169"/>
		</dbReference>
		<dbReference type="RefSeq" id="NP_000672.3">
			<property type="nucleotide sequence ID" value="NM_000681.3"/>
		</dbReference>
		<dbReference type="UniGene" id="Hs.249159"/>
		<dbReference type="PDB" id="1HLL">
			<property type="method" value="NMR"/>
			<property type="chains" value="A=118-149"/>
		</dbReference>
		<dbReference type="PDB" id="1HO9">
			<property type="method" value="NMR"/>
			<property type="chains" value="A=118-149"/>
		</dbReference>
		<dbReference type="PDB" id="1HOD">
			<property type="method" value="NMR"/>
			<property type="chains" value="A=118-149"/>
		</dbReference>
		<dbReference type="PDB" id="1HOF">
			<property type="method" value="NMR"/>
			<property type="chains" value="A=118-149"/>
		</dbReference>
		<dbReference type="PDBsum" id="1HLL"/>
		<dbReference type="PDBsum" id="1HO9"/>
		<dbReference type="PDBsum" id="1HOD"/>
		<dbReference type="PDBsum" id="1HOF"/>
		<dbReference type="ProteinModelPortal" id="P08913"/>
		<dbReference type="SMR" id="P08913">
			<property type="residue range" value="37-443"/>
		</dbReference>
		<dbReference type="STRING" id="P08913"/>
		<dbReference type="PhosphoSite" id="P08913"/>
		<dbReference type="DMDM" id="1351829"/>
		<dbReference type="PRIDE" id="P08913"/>
		<dbReference type="DNASU" id="150"/>
		<dbReference type="Ensembl" id="ENST00000280155">
			<property type="protein sequence ID" value="ENSP00000280155"/>
			<property type="gene ID" value="ENSG00000150594"/>
		</dbReference>
		<dbReference type="Ensembl" id="ENST00000449894">
			<property type="protein sequence ID" value="ENSP00000397995"/>
			<property type="gene ID" value="ENSG00000150594"/>
		</dbReference>
		<dbReference type="GeneID" id="150"/>
		<dbReference type="KEGG" id="hsa:150"/>
		<dbReference type="UCSC" id="uc001kzo.3">
			<property type="organism name" value="human"/>
		</dbReference>
		<dbReference type="CTD" id="150"/>
		<dbReference type="GeneCards" id="GC10P112826"/>
		<dbReference type="H-InvDB" id="HIX0025918"/>
		<dbReference type="HGNC" id="HGNC:281">
			<property type="gene designation" value="ADRA2A"/>
		</dbReference>
		<dbReference type="MIM" id="104210">
			<property type="type" value="gene"/>
		</dbReference>
		<dbReference type="neXtProt" id="NX_P08913"/>
		<dbReference type="PharmGKB" id="PA35"/>
		<dbReference type="eggNOG" id="NOG249628"/>
		<dbReference type="HOGENOM" id="HOG000239242"/>
		<dbReference type="HOVERGEN" id="HBG106962"/>
		<dbReference type="InParanoid" id="P08913"/>
		<dbReference type="KO" id="K04138"/>
		<dbReference type="OrthoDB" id="EOG4R502W"/>
		<dbReference type="PhylomeDB" id="P08913"/>
		<dbReference type="Reactome" id="REACT_111102">
			<property type="pathway name" value="Signal Transduction"/>
		</dbReference>
		<dbReference type="Reactome" id="REACT_111217">
			<property type="pathway name" value="Metabolism"/>
		</dbReference>
		<dbReference type="Reactome" id="REACT_604">
			<property type="pathway name" value="Hemostasis"/>
		</dbReference>
		<dbReference type="DrugBank" id="DB00321">
			<property type="generic name" value="Amitriptyline"/>
		</dbReference>
		<dbReference type="DrugBank" id="DB00182">
			<property type="generic name" value="Amphetamine"/>
		</dbReference>
		<dbReference type="DrugBank" id="DB00964">
			<property type="generic name" value="Apraclonidine"/>
		</dbReference>
		<dbReference type="DrugBank" id="DB00865">
			<property type="generic name" value="Benzphetamine"/>
		</dbReference>
		<dbReference type="DrugBank" id="DB00217">
			<property type="generic name" value="Bethanidine"/>
		</dbReference>
		<dbReference type="DrugBank" id="DB00484">
			<property type="generic name" value="Brimonidine"/>
		</dbReference>
		<dbReference type="DrugBank" id="DB00575">
			<property type="generic name" value="Clonidine"/>
		</dbReference>
		<dbReference type="DrugBank" id="DB04840">
			<property type="generic name" value="Debrisoquin"/>
		</dbReference>
		<dbReference type="DrugBank" id="DB00633">
			<property type="generic name" value="Dexmedetomidine"/>
		</dbReference>
		<dbReference type="DrugBank" id="DB00449">
			<property type="generic name" value="Dipivefrin"/>
		</dbReference>
		<dbReference type="DrugBank" id="DB00751">
			<property type="generic name" value="Epinastine"/>
		</dbReference>
		<dbReference type="DrugBank" id="DB00696">
			<property type="generic name" value="Ergotamine"/>
		</dbReference>
		<dbReference type="DrugBank" id="DB00800">
			<property type="generic name" value="Fenoldopam"/>
		</dbReference>
		<dbReference type="DrugBank" id="DB00629">
			<property type="generic name" value="Guanabenz"/>
		</dbReference>
		<dbReference type="DrugBank" id="DB00226">
			<property type="generic name" value="Guanadrel Sulfate"/>
		</dbReference>
		<dbReference type="DrugBank" id="DB01170">
			<property type="generic name" value="Guanethidine"/>
		</dbReference>
		<dbReference type="DrugBank" id="DB01018">
			<property type="generic name" value="Guanfacine"/>
		</dbReference>
		<dbReference type="DrugBank" id="DB04948">
			<property type="generic name" value="Lofexidine"/>
		</dbReference>
		<dbReference type="DrugBank" id="DB00968">
			<property type="generic name" value="Methyldopa"/>
		</dbReference>
		<dbReference type="DrugBank" id="DB06148">
			<property type="generic name" value="Mianserin"/>
		</dbReference>
		<dbReference type="DrugBank" id="DB00370">
			<property type="generic name" value="Mirtazapine"/>
		</dbReference>
		<dbReference type="DrugBank" id="DB00368">
			<property type="generic name" value="Norepinephrine"/>
		</dbReference>
		<dbReference type="DrugBank" id="DB00935">
			<property type="generic name" value="Oxymetazoline"/>
		</dbReference>
		<dbReference type="DrugBank" id="DB00692">
			<property type="generic name" value="Phentolamine"/>
		</dbReference>
		<dbReference type="DrugBank" id="DB00397">
			<property type="generic name" value="Phenylpropanolamine"/>
		</dbReference>
		<dbReference type="DrugBank" id="DB00852">
			<property type="generic name" value="Pseudoephedrine"/>
		</dbReference>
		<dbReference type="DrugBank" id="DB00697">
			<property type="generic name" value="Tizanidine"/>
		</dbReference>
		<dbReference type="DrugBank" id="DB00656">
			<property type="generic name" value="Trazodone"/>
		</dbReference>
		<dbReference type="DrugBank" id="DB01392">
			<property type="generic name" value="Yohimbine"/>
		</dbReference>
		<dbReference type="EvolutionaryTrace" id="P08913"/>
		<dbReference type="NextBio" id="595"/>
		<dbReference type="ArrayExpress" id="P08913"/>
		<dbReference type="Bgee" id="P08913"/>
		<dbReference type="CleanEx" id="HS_ADRA2A"/>
		<dbReference type="Genevestigator" id="P08913"/>
		<dbReference type="GermOnline" id="ENSG00000150594">
			<property type="organism name" value="Homo sapiens"/>
		</dbReference>
		<dbReference type="GO" id="GO:0016323">
			<property type="term" value="C:basolateral plasma membrane"/>
			<property type="evidence" value="TAS:BHF-UCL"/>
		</dbReference>
		<dbReference type="GO" id="GO:0005737">
			<property type="term" value="C:cytoplasm"/>
			<property type="evidence" value="IDA:BHF-UCL"/>
		</dbReference>
		<dbReference type="GO" id="GO:0005887">
			<property type="term" value="C:integral to plasma membrane"/>
			<property type="evidence" value="IDA:BHF-UCL"/>
		</dbReference>
		<dbReference type="GO" id="GO:0043235">
			<property type="term" value="C:receptor complex"/>
			<property type="evidence" value="IDA:BHF-UCL"/>
		</dbReference>
		<dbReference type="GO" id="GO:0031692">
			<property type="term" value="F:alpha-1B adrenergic receptor binding"/>
			<property type="evidence" value="ISS:BHF-UCL"/>
		</dbReference>
		<dbReference type="GO" id="GO:0031696">
			<property type="term" value="F:alpha-2C adrenergic receptor binding"/>
			<property type="evidence" value="IPI:BHF-UCL"/>
		</dbReference>
		<dbReference type="GO" id="GO:0004938">
			<property type="term" value="F:alpha2-adrenergic receptor activity"/>
			<property type="evidence" value="IDA:BHF-UCL"/>
		</dbReference>
		<dbReference type="GO" id="GO:0051379">
			<property type="term" value="F:epinephrine binding"/>
			<property type="evidence" value="IDA:BHF-UCL"/>
		</dbReference>
		<dbReference type="GO" id="GO:0032795">
			<property type="term" value="F:heterotrimeric G-protein binding"/>
			<property type="evidence" value="IDA:BHF-UCL"/>
		</dbReference>
		<dbReference type="GO" id="GO:0051380">
			<property type="term" value="F:norepinephrine binding"/>
			<property type="evidence" value="IDA:BHF-UCL"/>
		</dbReference>
		<dbReference type="GO" id="GO:0046982">
			<property type="term" value="F:protein heterodimerization activity"/>
			<property type="evidence" value="IPI:BHF-UCL"/>
		</dbReference>
		<dbReference type="GO" id="GO:0042803">
			<property type="term" value="F:protein homodimerization activity"/>
			<property type="evidence" value="IDA:BHF-UCL"/>
		</dbReference>
		<dbReference type="GO" id="GO:0019901">
			<property type="term" value="F:protein kinase binding"/>
			<property type="evidence" value="IPI:BHF-UCL"/>
		</dbReference>
		<dbReference type="GO" id="GO:0031996">
			<property type="term" value="F:thioesterase binding"/>
			<property type="evidence" value="IPI:BHF-UCL"/>
		</dbReference>
		<dbReference type="GO" id="GO:0030036">
			<property type="term" value="P:actin cytoskeleton organization"/>
			<property type="evidence" value="TAS:ProtInc"/>
		</dbReference>
		<dbReference type="GO" id="GO:0071883">
			<property type="term"
								value="P:activation of MAPK activity by adrenergic receptor signaling pathway"/>
			<property type="evidence" value="IDA:BHF-UCL"/>
		</dbReference>
		<dbReference type="GO" id="GO:0071882">
			<property type="term"
								value="P:activation of phospholipase C activity by adrenergic receptor signaling pathway"/>
			<property type="evidence" value="IDA:BHF-UCL"/>
		</dbReference>
		<dbReference type="GO" id="GO:0032148">
			<property type="term" value="P:activation of protein kinase B activity"/>
			<property type="evidence" value="IDA:BHF-UCL"/>
		</dbReference>
		<dbReference type="GO" id="GO:0006928">
			<property type="term" value="P:cellular component movement"/>
			<property type="evidence" value="TAS:ProtInc"/>
		</dbReference>
		<dbReference type="GO" id="GO:0032870">
			<property type="term" value="P:cellular response to hormone stimulus"/>
			<property type="evidence" value="IGI:BHF-UCL"/>
		</dbReference>
		<dbReference type="GO" id="GO:0006112">
			<property type="term" value="P:energy reserve metabolic process"/>
			<property type="evidence" value="TAS:Reactome"/>
		</dbReference>
		<dbReference type="GO" id="GO:0035625">
			<property type="term"
								value="P:epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway"/>
			<property type="evidence" value="IDA:BHF-UCL"/>
		</dbReference>
		<dbReference type="GO" id="GO:0042593">
			<property type="term" value="P:glucose homeostasis"/>
			<property type="evidence" value="IMP:BHF-UCL"/>
		</dbReference>
		<dbReference type="GO" id="GO:0071881">
			<property type="term"
								value="P:inhibition of adenylate cyclase activity by adrenergic receptor signaling pathway"/>
			<property type="evidence" value="IDA:BHF-UCL"/>
		</dbReference>
		<dbReference type="GO" id="GO:0050892">
			<property type="term" value="P:intestinal absorption"/>
			<property type="evidence" value="TAS:BHF-UCL"/>
		</dbReference>
		<dbReference type="GO" id="GO:0071878">
			<property type="term"
								value="P:negative regulation of adrenergic receptor signaling pathway"/>
			<property type="evidence" value="ISS:BHF-UCL"/>
		</dbReference>
		<dbReference type="GO" id="GO:0051927">
			<property type="term"
								value="P:negative regulation of calcium ion transport via voltage-gated calcium channel activity"/>
			<property type="evidence" value="ISS:BHF-UCL"/>
		</dbReference>
		<dbReference type="GO" id="GO:0045955">
			<property type="term"
								value="P:negative regulation of calcium ion-dependent exocytosis"/>
			<property type="evidence" value="IC:BHF-UCL"/>
		</dbReference>
		<dbReference type="GO" id="GO:0032811">
			<property type="term"
								value="P:negative regulation of epinephrine secretion"/>
			<property type="evidence" value="NAS:BHF-UCL"/>
		</dbReference>
		<dbReference type="GO" id="GO:0061179">
			<property type="term"
								value="P:negative regulation of insulin secretion involved in cellular response to glucose stimulus"/>
			<property type="evidence" value="IMP:BHF-UCL"/>
		</dbReference>
		<dbReference type="GO" id="GO:0050995">
			<property type="term"
								value="P:negative regulation of lipid catabolic process"/>
			<property type="evidence" value="IGI:BHF-UCL"/>
		</dbReference>
		<dbReference type="GO" id="GO:0010700">
			<property type="term"
								value="P:negative regulation of norepinephrine secretion"/>
			<property type="evidence" value="NAS:BHF-UCL"/>
		</dbReference>
		<dbReference type="GO" id="GO:0030168">
			<property type="term" value="P:platelet activation"/>
			<property type="evidence" value="TAS:Reactome"/>
		</dbReference>
		<dbReference type="GO" id="GO:0030335">
			<property type="term" value="P:positive regulation of cell migration"/>
			<property type="evidence" value="IMP:BHF-UCL"/>
		</dbReference>
		<dbReference type="GO" id="GO:0008284">
			<property type="term"
								value="P:positive regulation of cell proliferation"/>
			<property type="evidence" value="TAS:ProtInc"/>
		</dbReference>
		<dbReference type="GO" id="GO:0001819">
			<property type="term"
								value="P:positive regulation of cytokine production"/>
			<property type="evidence" value="IDA:BHF-UCL"/>
		</dbReference>
		<dbReference type="GO" id="GO:0051044">
			<property type="term"
								value="P:positive regulation of membrane protein ectodomain proteolysis"/>
			<property type="evidence" value="IDA:BHF-UCL"/>
		</dbReference>
		<dbReference type="GO" id="GO:0043268">
			<property type="term"
								value="P:positive regulation of potassium ion transport"/>
			<property type="evidence" value="ISS:BHF-UCL"/>
		</dbReference>
		<dbReference type="GO" id="GO:0090303">
			<property type="term" value="P:positive regulation of wound healing"/>
			<property type="evidence" value="IMP:BHF-UCL"/>
		</dbReference>
		<dbReference type="GO" id="GO:0007266">
			<property type="term" value="P:Rho protein signal transduction"/>
			<property type="evidence" value="TAS:ProtInc"/>
		</dbReference>
		<dbReference type="GO" id="GO:0044281">
			<property type="term" value="P:small molecule metabolic process"/>
			<property type="evidence" value="TAS:Reactome"/>
		</dbReference>
		<dbReference type="InterPro" id="IPR000276">
			<property type="entry name" value="7TM_GPCR_Rhodpsn"/>
		</dbReference>
		<dbReference type="InterPro" id="IPR001946">
			<property type="entry name" value="Adren_rcpt_A2A"/>
		</dbReference>
		<dbReference type="InterPro" id="IPR002233">
			<property type="entry name" value="Adrnrgc_rcpt"/>
		</dbReference>
		<dbReference type="InterPro" id="IPR017452">
			<property type="entry name" value="GPCR_Rhodpsn_supfam"/>
		</dbReference>
		<dbReference type="Pfam" id="PF00001">
			<property type="entry name" value="7tm_1"/>
			<property type="match status" value="1"/>
		</dbReference>
		<dbReference type="PRINTS" id="PR01103">
			<property type="entry name" value="ADRENERGICR"/>
		</dbReference>
		<dbReference type="PRINTS" id="PR00558">
			<property type="entry name" value="ADRENRGCA2AR"/>
		</dbReference>
		<dbReference type="PRINTS" id="PR00237">
			<property type="entry name" value="GPCRRHODOPSN"/>
		</dbReference>
		<dbReference type="PROSITE" id="PS00237">
			<property type="entry name" value="G_PROTEIN_RECEP_F1_1"/>
			<property type="match status" value="1"/>
		</dbReference>
		<dbReference type="PROSITE" id="PS50262">
			<property type="entry name" value="G_PROTEIN_RECEP_F1_2"/>
			<property type="match status" value="1"/>
		</dbReference>
		<proteinExistence type="evidence at protein level"/>
		<keyword id="KW-0002">3D-structure</keyword>
		<keyword id="KW-1003">Cell membrane</keyword>
		<keyword id="KW-0181">Complete proteome</keyword>
		<keyword id="KW-0903">Direct protein sequencing</keyword>
		<keyword id="KW-1015">Disulfide bond</keyword>
		<keyword id="KW-0297">G-protein coupled receptor</keyword>
		<keyword id="KW-0325">Glycoprotein</keyword>
		<keyword id="KW-0449">Lipoprotein</keyword>
		<keyword id="KW-0472">Membrane</keyword>
		<keyword id="KW-0564">Palmitate</keyword>
		<keyword id="KW-0597">Phosphoprotein</keyword>
		<keyword id="KW-0621">Polymorphism</keyword>
		<keyword id="KW-0675">Receptor</keyword>
		<keyword id="KW-1185">Reference proteome</keyword>
		<keyword id="KW-0807">Transducer</keyword>
		<keyword id="KW-0812">Transmembrane</keyword>
		<keyword id="KW-1133">Transmembrane helix</keyword>
		<feature type="chain" description="Alpha-2A adrenergic receptor"
						 id="PRO_0000069080">
			<location>
				<begin position="1"/>
				<end position="450"/>
			</location>
		</feature>
		<feature type="topological domain" description="Extracellular"
						 status="by similarity">
			<location>
				<begin position="1"/>
				<end position="33"/>
			</location>
		</feature>
		<feature type="transmembrane region" description="Helical; Name=1;"
						 status="by similarity">
			<location>
				<begin position="34"/>
				<end position="59"/>
			</location>
		</feature>
		<feature type="topological domain" description="Cytoplasmic"
						 status="by similarity">
			<location>
				<begin position="60"/>
				<end position="70"/>
			</location>
		</feature>
		<feature type="transmembrane region" description="Helical; Name=2;"
						 status="by similarity">
			<location>
				<begin position="71"/>
				<end position="96"/>
			</location>
		</feature>
		<feature type="topological domain" description="Extracellular"
						 status="by similarity">
			<location>
				<begin position="97"/>
				<end position="106"/>
			</location>
		</feature>
		<feature type="transmembrane region" description="Helical; Name=3;"
						 status="by similarity">
			<location>
				<begin position="107"/>
				<end position="129"/>
			</location>
		</feature>
		<feature type="topological domain" description="Cytoplasmic"
						 status="by similarity">
			<location>
				<begin position="130"/>
				<end position="151"/>
			</location>
		</feature>
		<feature type="transmembrane region" description="Helical; Name=4;"
						 status="by similarity">
			<location>
				<begin position="152"/>
				<end position="172"/>
			</location>
		</feature>
		<feature type="topological domain" description="Extracellular"
						 status="by similarity">
			<location>
				<begin position="173"/>
				<end position="194"/>
			</location>
		</feature>
		<feature type="transmembrane region" description="Helical; Name=5;"
						 status="by similarity">
			<location>
				<begin position="195"/>
				<end position="217"/>
			</location>
		</feature>
		<feature type="topological domain" description="Cytoplasmic"
						 status="by similarity">
			<location>
				<begin position="218"/>
				<end position="374"/>
			</location>
		</feature>
		<feature type="transmembrane region" description="Helical; Name=6;"
						 status="by similarity">
			<location>
				<begin position="375"/>
				<end position="395"/>
			</location>
		</feature>
		<feature type="topological domain" description="Extracellular"
						 status="by similarity">
			<location>
				<begin position="396"/>
				<end position="409"/>
			</location>
		</feature>
		<feature type="transmembrane region" description="Helical; Name=7;"
						 status="by similarity">
			<location>
				<begin position="410"/>
				<end position="429"/>
			</location>
		</feature>
		<feature type="topological domain" description="Cytoplasmic"
						 status="by similarity">
			<location>
				<begin position="430"/>
				<end position="450"/>
			</location>
		</feature>
		<feature type="site" description="Implicated in ligand binding">
			<location>
				<position position="113"/>
			</location>
		</feature>
		<feature type="site"
						 description="Implicated in catechol agonist binding and receptor activation">
			<location>
				<position position="200"/>
			</location>
		</feature>
		<feature type="site"
						 description="Implicated in catechol agonist binding and receptor activation">
			<location>
				<position position="204"/>
			</location>
		</feature>
		<feature type="modified residue" description="Phosphoserine" evidence="1">
			<location>
				<position position="297"/>
			</location>
		</feature>
		<feature type="modified residue" description="Phosphoserine" evidence="1">
			<location>
				<position position="298"/>
			</location>
		</feature>
		<feature type="modified residue" description="Phosphoserine" evidence="1">
			<location>
				<position position="299"/>
			</location>
		</feature>
		<feature type="lipid moiety-binding region"
						 description="S-palmitoyl cysteine" status="by similarity">
			<location>
				<position position="442"/>
			</location>
		</feature>
		<feature type="glycosylation site" description="N-linked (GlcNAc...)"
						 status="potential">
			<location>
				<position position="10"/>
			</location>
		</feature>
		<feature type="glycosylation site" description="N-linked (GlcNAc...)"
						 status="potential">
			<location>
				<position position="14"/>
			</location>
		</feature>
		<feature type="disulfide bond" status="by similarity">
			<location>
				<begin position="106"/>
				<end position="188"/>
			</location>
		</feature>
		<feature type="sequence variant"
						 description="Rare polymorphism; frequency in Caucasians 0.004 and in African-Americans 0.05; 40% increase in agonist-promoted Gi coupling; dbSNP:rs1800035."
						 id="VAR_014957" evidence="2 3 4">
			<original>N</original>
			<variation>K</variation>
			<location>
				<position position="251"/>
			</location>
		</feature>
		<feature type="sequence variant" description="In dbSNP:rs35658213."
						 id="VAR_055908">
			<original>C</original>
			<variation>S</variation>
			<location>
				<position position="401"/>
			</location>
		</feature>
		<feature type="mutagenesis site"
						 description="No change in binding affinity. eliminates guanine nucleotide-sensitive agonist binding."
						 evidence="5">
			<original>D</original>
			<variation>N</variation>
			<location>
				<position position="79"/>
			</location>
		</feature>
		<feature type="mutagenesis site"
						 description="No binding to yohimbine. Increase in adenylate cyclase activity."
						 evidence="5">
			<original>D</original>
			<variation>N</variation>
			<location>
				<position position="113"/>
			</location>
		</feature>
		<feature type="mutagenesis site"
						 description="Lower affinity for agonists. Eliminates guanine nucleotide-sensitive agonist binding."
						 evidence="5">
			<original>D</original>
			<variation>N</variation>
			<location>
				<position position="130"/>
			</location>
		</feature>
		<feature type="mutagenesis site"
						 description="Lower affinity for agonists. No change in guanine nucleotide-sensitive agonist binding."
						 evidence="5">
			<original>S</original>
			<variation>A</variation>
			<location>
				<position position="200"/>
			</location>
		</feature>
		<feature type="mutagenesis site"
						 description="Lower affinity for agonists. Reduced guanine nucleotide-sensitive agonist binding."
						 evidence="5">
			<original>S</original>
			<variation>A</variation>
			<location>
				<position position="204"/>
			</location>
		</feature>
		<feature type="mutagenesis site"
						 description="350-fold reduced affinity for alpha-2 antagonist yohimbine, 3000-fold increase for beta-antagonist alprenolol."
						 evidence="5 6">
			<original>F</original>
			<variation>N</variation>
			<location>
				<position position="412"/>
			</location>
		</feature>
		<feature type="sequence conflict" description="In Ref. 1; AAA51664."
						 ref="1">
			<original>A</original>
			<variation>T</variation>
			<location>
				<position position="104"/>
			</location>
		</feature>
		<feature type="sequence conflict" description="In Ref. 13." ref="13">
			<original>L</original>
			<variation>P</variation>
			<location>
				<position position="124"/>
			</location>
		</feature>
		<feature type="sequence conflict" description="In Ref. 1; AAA51664."
						 ref="1">
			<original>V</original>
			<variation>C</variation>
			<location>
				<position position="157"/>
			</location>
		</feature>
		<feature type="sequence conflict"
						 description="In Ref. 1; AAA51664 and 2; AAA51665." ref="1 2">
			<original>PRRGPGATGIGTPAAGPGEERVGAAKASRWRGR</original>
			<variation>RGAGRGRRGSGRRLQGRGRSASGLPRRRAGAGG</variation>
			<location>
				<begin position="333"/>
				<end position="365"/>
			</location>
		</feature>
		<feature type="sequence conflict" description="In Ref. 1; AAA51664."
						 ref="1">
			<original>R</original>
			<variation>L</variation>
			<location>
				<position position="368"/>
			</location>
		</feature>
		<feature type="helix">
			<location>
				<begin position="119"/>
				<end position="128"/>
			</location>
		</feature>
		<feature type="helix">
			<location>
				<begin position="130"/>
				<end position="139"/>
			</location>
		</feature>
		<feature type="helix">
			<location>
				<begin position="140"/>
				<end position="142"/>
			</location>
		</feature>
		<evidence key="1" type="ECO:0000006">
			<source>
				<dbReference type="PubMed" id="17081983"/>
			</source>
		</evidence>
		<evidence key="2" type="ECO:0000006">
			<source>
				<dbReference type="PubMed" id="10948191"/>
			</source>
		</evidence>
		<evidence key="3" type="ECO:0000006">
			<source>
				<dbReference type="PubMed" id="16567612"/>
			</source>
		</evidence>
		<evidence key="4" type="ECO:0000006">
			<source ref="9"/>
		</evidence>
		<evidence key="5" type="ECO:0000006">
			<source>
				<dbReference type="PubMed" id="1678850"/>
			</source>
		</evidence>
		<evidence key="6" type="ECO:0000006">
			<source>
				<dbReference type="PubMed" id="1678390"/>
			</source>
		</evidence>
		<sequence length="450" mass="48957" checksum="A703CF262F04E8AC"
							modified="1996-02-01" version="3">
			MGSLQPDAGNASWNGTEAPGGGARATPYSLQVTLTLVCLAGLLMLLTVFGNVLVIIAVFT
			SRALKAPQNLFLVSLASADILVATLVIPFSLANEVMGYWYFGKAWCEIYLALDVLFCTSS
			IVHLCAISLDRYWSITQAIEYNLKRTPRRIKAIIITVWVISAVISFPPLISIEKKGGGGG
			PQPAEPRCEINDQKWYVISSCIGSFFAPCLIMILVYVRIYQIAKRRTRVPPSRRGPDAVA
			APPGGTERRPNGLGPERSAGPGGAEAEPLPTQLNGAPGEPAPAGPRDTDALDLEESSSSD
			HAERPPGPRRPERGPRGKGKARASQVKPGDSLPRRGPGATGIGTPAAGPGEERVGAAKAS
			RWRGRQNREKRFTFVLAVVIGVFVVCWFPFFFTYTLTAVGCSVPRTLFKFFFWFGYCNSS
			LNPVIYTIFNHDFRRAFKKILCRGDRKRIV
		</sequence>
	</entry>
	<copyright>Copyrighted by the UniProt Consortium, see
		http://www.uniprot.org/terms Distributed under the Creative Commons
		Attribution-NoDerivs License
	</copyright>
</uniprot>